Detalhe da pesquisa
1.
Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents.
Cell
; 186(5): 1013-1025.e24, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827973
2.
Inhibitors of Civ1 kinase belonging to 6-aminoaromatic-2-cyclohexyldiamino purine series as potent anti-fungal compounds.
Biochim Biophys Acta
; 1697(1-2): 211-23, 2004 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-15023362
3.
Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins.
Science
; 348(6239): 1106-12, 2015 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26045430
4.
The cell cycle of pathogenic fungi: target for drugs.
Prog Cell Cycle Res
; 5: 81-90, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14593703
5.
Complete glycosylphosphatidylinositol anchors are required in Candida albicans for full morphogenesis, virulence and resistance to macrophages.
Mol Microbiol
; 44(3): 841-53, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11994163